Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics Analyst Ratings

• Total Analysts: 9
• Consensus Rating: Strong Buy
• Price Target: $40.38
• Upside: +161.61%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell S. Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+191.55%	Aug 18, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+191.55%	Jul 23, 2025
Martin Fan Wedbush	Wedbush	Buy Reiterates $40	Buy	Reiterates	$40	+159.15%	May 15, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+191.55%	Feb 7, 2025
Andy Chen Wolfe Research	Wolfe Research	Buy Initiates $20	Buy	Initiates	$20	+29.58%	Feb 4, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+191.55%	Dec 20, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+191.55%	Nov 25, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+191.55%	Oct 31, 2024
Alex Thompson Stifel	Stifel	Strong Buy Initiates $49	Strong Buy	Initiates	$49	+217.46%	Oct 11, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $45	Strong Buy	Initiates	$45	+191.55%	Oct 7, 2024
David Risinger Leerink Partners	Leerink Partners	Buy Initiates $44	Buy	Initiates	$44	+185.07%	Sep 17, 2024
David Risinger Leerink Swann	Leerink Swann	Buy Initiates $44	Buy	Initiates	$44	+185.07%	Sep 17, 2024
Tyler Van Buren TD Cowen	TD Cowen	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Sep 16, 2024
Michael Yee Jefferies	Jefferies	Strong Buy Initiates $40	Strong Buy	Initiates	$40	+159.15%	Sep 13, 2024
David Nierengarten Wedbush	Wedbush	Buy Initiates $40	Buy	Initiates	$40	+159.15%	Sep 4, 2024